High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.6M
$2,555,570
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MASI |
MASIMO CORP
|
CEO
Other
|
2026-02-12 | $1,481,307Large | M | Form 4 |
|
MASI
M
MASIMO CORP
Sampath Anand
• Officer • EVP, Ops & Clinical Research
Other
2026-01-28
$1,135,200Large
|
||||||
| MASI |
MASIMO CORP
|
Officer • EVP, Ops & Clinical Research
Other
|
2026-01-28 | $1,135,200Large | M | Form 4 |
|
MASI
S
MASIMO CORP
Sampath Anand
• Officer • EVP, Ops & Clinical Research
10b5-1 SellΔOwn -20.0%
2026-01-28
$1,628,341Large
|
||||||
| MASI |
MASIMO CORP
|
Officer • EVP, Ops & Clinical Research
10b5-1 SellΔOwn -20.0%
|
2026-01-28 | $1,628,341Large | S | Form 4 |
|
MASI
S
MASIMO CORP
Sampath Anand
• Officer • EVP, Ops & Clinical Research
10b5-1 SellΔOwn -13.8%
2026-01-28
$900,163
|
||||||
| MASI |
MASIMO CORP
|
Officer • EVP, Ops & Clinical Research
10b5-1 SellΔOwn -13.8%
|
2026-01-28 | $900,163 | S | Form 4 |
|
MASI
S
MASIMO CORP
Sampath Anand
• Officer • EVP, Ops & Clinical Research
10b5-1 Sell
2026-01-28
$27,066
|
||||||
| MASI |
MASIMO CORP
|
Officer • EVP, Ops & Clinical Research
10b5-1 Sell
|
2026-01-28 | $27,066 | S | Form 4 |
| MASI |
MASIMO CORP
|
Officer • CTIO & EVP of Engineering
Other
|
2025-11-13 | $377,112 | M | Form 4 |
| MASI |
MASIMO CORP
|
COO
Other
|
2025-09-23 | $2,131,950Large | M | Form 4 |